The U.S. Food and Drug Administration (FDA) has issued a final rule to amend its regulations on how and when FDA may determine that a food contact notification (FCN) is no longer effective.
CARBIOS Active, an enzymatic solution for 100 percent compostable polylactic acid (PLA) packaging, has been added to the U.S. Food and Drug Administration (FDA) Inventory of Effective Food Contact Substances.
As part of its post-implementation review process, the UK Food Standards Agency (FSA) has opened consultations on two regulations related to food contact materials and plastic kitchenware.
The UK Food Standards Agency (FSA) has alerted businesses that they should not sell plastic food contact materials containing bamboo and other plant-based materials, and have put out a call for evidence related to their safety and stability.
A new guidance document from ILSI Europe on the existing approaches for analyzing Non-Intentionally Added Substances (NIAS) from different food contact materials has been released.
The European Food Safety Authority (EFSA) has determined the food safety of plastic polyethylene terephthalate (PET) when produced by a recycling process called Poly Recycling for use in food contact materials.
The European Food Safety Authority (EFSA) recently highlighted various fellowship projects across Europe, providing insight into the recent and ongoing work of EFSA in the realm of food safety risk assessment for various chemical and microbiological hazards.
The European Food Safety Authority (EFSA) will be reevaluating the health risks posed by phthalates and replacement plasticizers used in food contact materials, and has recently published its scientific protocol for the hazard assessment of the substances.
Scientists at Northwestern Medicine have demonstrated a causal link between di-(2-ethylhexyl) (DEHP), a phthalate commonly used in food packaging, and uterine fibroid growth.
After conducting a study on the U.S. Food and Drug Administration’s (FDA’s) oversight of substances used in food contact materials, the U.S. Government Accountability Office (GAO) recommended that FDA request certain authorities from Congress in order to adequately review the safety of such substances.